Brain Protein Levels Predict Heart Damage Risk in Kawasaki Disease

AI Insight

This is a correction notice for a previously published meta-analysis that examined the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and coronary artery lesions in patients with Kawasaki disease. The correction addresses errors or issues in the original article that investigated whether NT-proBNP biomarker levels could serve as indicators for coronary artery complications in pediatric Kawasaki disease patients.

Why it matters

Kawasaki disease is a leading cause of acquired heart disease in children, and identifying reliable biomarkers for predicting coronary artery lesions is crucial for early intervention and treatment decisions. Accurate meta-analyses help clinicians understand whether NT-proBNP testing can effectively identify at-risk patients who may require more intensive monitoring or therapy.